Olmesartan

Class Angiotensin receptor blocker
Chemistry

Imidazole analogue

Routes of administration

Oral

Absorption

26% oral bioavailability

Solubility

pKa unknown

Distribution

0.24 L/kg

Metabolism

60% hepatic metabolism

Elimination

40% renally excreted unchanged

Time course of action

Effects are maximal ~ 1 hour following oral administration

Target receptor

AT1 receptor

Mechanism of action

By interfering with the binding of Angiotensin-II and its receptor (by competitive inhibition), tthis drug interrupts the effects of renin-angiotensin-aldosterone system activation, which are mainly mediated by Angiotensin II via the AT1 receptor.

Clinical effects

Vasodilation (without reflex tachycardia), increased natriuresis, increased sensitivity to diuretics, decreased glomerular filtration. Positive effects of vascular and myocardial remodelling in CCF. angioedema.

Literature reference

Miura et al (2011)

CICM details of understanding Not specifically listed in the CICM syllabus
Mentioned around Deranged Physiology
Related SAQs